namic diameter of 1-3 μm are deposited minimally in the mouth and throat and maximally in the lung parenchymal regions, such as the alveolar or deep-lung region 5 . Thus, inhalable nanocomposite particles are a promising inhalation system. Furthermore, nanoparticles can overcome mucus clearance 6 . In addition to macrophages, they are also taken up by other cells such as cancer cells and epithelial cells 7 10 . These properties of nanoparticles are useful for drug delivery; however, the size of nanoparticles is not suitable for inhalation. Nanocomposite particles with an aerodynamic diameter suitable for inhalation are used to solve this problem. Since these particles use diluents soluble in the alveoli lining fluid, they are decomposed into nanoparticles after reaching the alveoli 10 . Recently, it was reported that nanocomposite particles for inhalation improved the concentration of drug in the lungs. These